Pharmaust Limited (AU:NUZ)
ASX:NUZ
Australian Market

Pharmaust Limited (NUZ) Technical Analysis

Compare
21 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
1Bullish
0Neutral
12Bearish
Technical Analysis Consensus
Strong Buy
1Bullish
0Neutral
0Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Pharmaust Limited’s (NUZ) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Pharmaust Limited is a Sell.
Pharmaust Limited’s (NUZ) 20-Day exponential moving average is 0.12, while Pharmaust Limited’s (NUZ) share price is AU$0.11, making it a Sell.
Pharmaust Limited’s (NUZ) 50-Day exponential moving average is 0.13, while Pharmaust Limited’s (NUZ) share price is AU$0.11, making it a Sell.

Pharmaust Limited (NUZ) Pivot Points

Apr 06, 2025, 11:11 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.11
0.12
0.12
0.13
0.14
0.15
0.15
Fibonacci
0.12
0.12
0.13
0.13
0.14
0.14
0.15
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pharmaust Limited (NUZ) Moving Averages

Apr 06, 2025, 11:11 PM
Period
Simple
Exponential
MA5
0.12Sell
0.12Sell
MA10
0.12Sell
0.12Sell
MA20
0.11Sell
0.12Sell
MA50
0.13Sell
0.13Sell
MA100
0.15Sell
0.14Sell
MA200
0.17Sell
0.17Sell
Pharmaust Limited’s (NUZ) 10-Day exponential moving average is 0.12, while Pharmaust Limited’s (NUZ) share price is AU$0.11, making it a Sell.
Pharmaust Limited’s (NUZ) 100-Day exponential moving average is 0.14, while Pharmaust Limited’s (NUZ) share price is AU$0.11, making it a Sell.
Pharmaust Limited’s (NUZ) stock price is AU$0.11 and Pharmaust Limited’s (NUZ) 50-day simple moving average is 0.13, creating a Sell signal.
Pharmaust Limited’s (NUZ) stock price is AU$0.11 and Pharmaust Limited’s (NUZ) 100-day simple moving average is 0.15, creating a Sell signal.
Pharmaust Limited’s (NUZ) stock price is AU$0.11 and Pharmaust Limited’s (NUZ) 200-day simple moving average is 0.17, creating a Sell signal.

Pharmaust Limited (NUZ) Technical Indicators

Apr 06, 2025, 11:11 PM
Name
Value
Implied Action
RSI (14)
53.18
Neutral
STOCH (9,6)
81.06
Sell
STOCHRSI (14)
81.06
Sell
MACD (12,26)
>-0.01
Sell
ADX (14)
27.75
Neutral
Williams %R
-34.09
Buy
CCI (14)
119.78
Sell
ATR (14)
0.01
-
Ultimate Oscillator
51.95
Neutral
ROC
10.00
Buy
Pharmaust Limited’s (NUZ) Relative Strength Index (RSI) is 53.18, creating a Neutral signal.
Pharmaust Limited’s (NUZ) Trend Strength Indicator (ADX) is 27.75, creating a Neutral signal.
Pharmaust Limited’s (NUZ) Commodity Channel Index (CCI) is 119.78, creating a Sell signal.
Pharmaust Limited’s (NUZ) Price Rate of Change (ROC) is 10.00, creating a Buy signal.

FAQ

Is NUZ a Buy, Hold, or Sell?
Based on NUZ’s technical indicators, NUZ is a Strong Sell.
    What is NUZ’s RSI (14)?
    NUZ’s RSI (14) is 53.18, which suggests NUZ is a Neutral.
      What is NUZ’s MACD?
      NUZ’s MACD is >-0.01, which suggests NUZ is a Sell.
        What is NUZ’s 5-day moving average?
        NUZ’s 5-day moving average is 0.12, which suggests NUZ is a Sell.
          What is NUZ’s 20-day moving average?
          NUZ 20-day moving average is 0.11, which suggests NUZ is a Sell.
            What is NUZ’s 50-day moving average?
            NUZ’s 50-day moving average is 0.13, which suggests NUZ is a Sell.
              What is NUZ’s 200-day moving average?
              NUZ’s 200-day moving average is 0.17, which suggests NUZ is a Sell.
                What is NUZ’s Williams % R (14)?
                NUZ’s Williams % R (14) is -34.09, which suggests NUZ is a Buy.
                  What is NUZ’s CCI (14)?
                  NUZ’s CCI (14) is 119.78, which suggests NUZ is a Sell.
                    What is the share price of Pharmaust Limited?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis